Sunday, April 12, 2009 7:53:18 PM
Re; CGRB/DNDN
"The DNDN loonies are certain that the abiraterone program is a conspiracy to deny Provenge its rightful place in the prostate-cancer pecking order."
Given that abiraterone is hitting the hormone pathways for PC it would seam likely to have little to no effect on Provenge uptake (which hopefully would be used concurrently with hormone therapy after radiation/surgery).
I do think it has taken over from Provenge for it's place on the PC over-hyped list though
"The DNDN loonies are certain that the abiraterone program is a conspiracy to deny Provenge its rightful place in the prostate-cancer pecking order."
Given that abiraterone is hitting the hormone pathways for PC it would seam likely to have little to no effect on Provenge uptake (which hopefully would be used concurrently with hormone therapy after radiation/surgery).
I do think it has taken over from Provenge for it's place on the PC over-hyped list though
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
